The United States is expected to announce a deal later today that would allow Saudi Arabia to develop a civilian nuclear programme, a move that would fulfil a long-held Saudi ambition but has already attracted concern in Israel and among some US lawmakers.
The Trump administration is set to reveal the details of the agreement this Wednesday, with reports suggesting the White House believes it will bring billions of dollars to American companies. The deal aims to pave the way for Saudi Arabia to establish a civilian nuclear power capability.
Critics of the deal fear that it could open the door for the kingdom to attain a nuclear weapon, despite its stated civilian purpose.
Concerns Over Proliferation Risks
Despite the administration's emphasis on economic benefits and civilian applications, the prospective agreement has drawn sharp criticism. Opponents, including some US lawmakers, fear the deal could facilitate Saudi Arabia's path to developing nuclear weapons, potentially destabilising an already volatile Middle East.
Saudi Arabia has long expressed its desire for a domestic nuclear energy programme to diversify its energy mix and reduce reliance on oil for domestic power generation. However, the kingdom has previously indicated it would seek to enrich uranium for its reactors, a process that is also a key step in creating nuclear weapons.

Administration Justifies Economic Benefits
The Trump administration has consistently highlighted the substantial economic opportunities for American firms in the construction and operation of Saudi nuclear facilities. Officials argue that such a deal is crucial for securing US influence in the region and ensuring American companies are at the forefront of global nuclear energy development.
The proposed agreement marks a significant moment in US-Saudi relations and could reshape the geopolitical landscape of the Middle East. Its announcement is expected to trigger intense scrutiny from international non-proliferation bodies and ignite further debate in Washington and beyond.
Discussion (0)
Sign in to join the discussion.